Therefore, it seems that OX40–OX40L signaling is more involved in the pathogenesis of MS, and humoral immunity (autoantibodies against AQP4) is predominantly involved in NMO pathogenesis. The gene discussed is TNFSF4; the disease is myeloid sarcoma.